EQT co-leads TravelPerk's USD 200 million Series E
EQT Growth co-leads the round, which values TravelPerk at USD 2.7 billion, alongside Atomico; round also joined by new investors Noteus Partners and Sequoia Capital, as well existing investors like General Catalyst, Kinnevik, Softbank Vision Fund, and Blackstone
Alongside the financing, TravelPerk announces that it has acquired Yokoy, a leading spend management platform, to create an integrated Travel and Expense Management platform
STOCKHOLM, Jan. 28, 2025 /PRNewswire/ -- EQT is pleased to announce that EQT Growth, which aims to support fast-growing technology companies as they continue to scale, has co-led a USD 200 million Series E in TravelPerk. The investment is also led by Atomico, with participation from Noteus Partners and Sequoia Capital, as well as existing investors, including Kinnevik, General Catalyst, Softbank Vision Fund, and Blackstone. The oversubscribed round brings TravelPerk's valuation to USD 2.7 billion.As companies face greater economic pressures and more complicated regulatory environments, they are increasingly looking for fully integrated solutions that bring travel and expenses together into one automated platform. TravelPerk's end-to-end experience simplifies business travel management, streamlining processes and helping companies better control costs. With the acquisition of Yokoy, a leading spend management platform, and through integrations with expense management partners, TravelPerk is well positioned to provide small & medium businesses in Europe and the US highly localized solutions that suit individual needs, while preserving freedom of choice and flexibility.Founded in 2015 and today headquartered in Barcelona, TravelPerk has recorded 50 percent annual growth over the last two years and reached EBITDA break-even at the end of 2024. The new funding will be used to further accelerate growth, with continued expansion into the US market alongside significant investments into product, technology and AI.Carolina Brochado, Partner at EQT Growth, who will join the TravelPerk Board, said: "TravelPerk is a clear digital-native leader in the multi-hundred-billion corporate travel market. Most small and mid-market businesses remain unmanaged and underserved in this space. Having followed the TravelPerk team for years, we've been consistently impressed by their focus, tenacity, and ambition in disrupting the industry. Their proprietary use of AI is among the best we've seen, enabling faster, smarter service for their customers. With the Yokoy acquisition, their product evolves into a true end-to-end T&E solution, further powered by AI.""Until now, customers had to make hard trade-offs: an integrated platform or separate, best-in-class travel and expense solutions. A platform delivering a great end-user experience or one focused on the experience for Finance," commented TravelPerk President and Chief Operating Officer, JC Taunay-Bucalo. "Customers don't have to compromise anymore. Now, they can have a leading travel management product built on the world's largest inventory, combined with an expense management product that works for their business."Avi Meir, TravelPerk CEO and Co-Founder, added: "Our focus has never been stronger as we expand across core markets, accelerate growth in the US, and now work to become the number one travel and expense management platform. Our partnership with Yokoy has already been a great success, and we are excited to take it to the next level by welcoming Phil, Devis, and the rest of the team to TravelPerk. We share a common vision for the role of AI reshaping the future of travel and expense management, and the innovation coming out of Yokoy's AI labs in Zurich is seriously impressive."
ContactEQT Press Office, press@eqtpartners.com
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/eqt-co-leads-travelperk-s-usd-200-million-series-e,c4096522
The following files are available for download:
https://mb.cision.com/Main/87/4096522/3227338.pdf
PR_EQT invests in Travelperk_28.01.25
https://news.cision.com/eqt/i/travelperks,c3371730
TravelPerks
View original content:https://www.prnewswire.co.uk/news-releases/eqt-co-leads-travelperks-usd-200-million-series-e-302362131.html
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 minutes ago
- Yahoo
Rehabilitation Equipment Market Size Hits USD 18.42 Billion in 2025, Set to Cross USD 37.34 Billion by 2034
The global rehabilitation equipment market size is calculated at USD 18.42 billion in 2025 and is expected to reach around USD 37.34 billion by 2034, growing at a CAGR of 8.34% for the forecasted period. Ottawa, July 25, 2025 (GLOBE NEWSWIRE) -- The global rehabilitation equipment market size was valued at USD 17 billion in 2024 and is predicted to hit around USD 37.34 billion by 2034, a study published by Towards Healthcare a sister firm of Precedence Research. The growth of the market is driven the growing demand from consumers for specialized equipment, and benefits offered by the equipment's with improved quality of life and faster recovery rate which fuels the growth of the Highlights of Rehabilitation Equipment Market: North America dominated the global rehabilitation equipment market share by 43% in 2024. Asia-Pacific is anticipated to grow at the fastest rate in the market during the forecast period. By type, the therapy equipment segment held a dominant presence in the market in 2024. By type, the daily living aids segment is expected to grow at the fastest rate in the market during the forecast period. By application, the occupational rehabilitation & training segment led the global market in 2024. By application, the physical rehabilitation & training segment is anticipated to grow with the highest CAGR in the market during the studied years. By end-use, the hospitals & clinics segment held the largest share of the market in 2024. By end-use, the rehabilitation centers segment is predicted to witness significant growth in the market over the forecast period. Market Overview & Potential What are Rehabilitation Equipment? Rehabilitation equipment includes various tools and devices that assist individuals in recovery from injuries, surgeries, or illnesses, helping them restore lost abilities. These tools aim to enhance mobility, strength, coordination, and independence. Main categories include Mobility Aids such as wheelchairs, walkers, canes, and crutches; Prosthetics and orthotics; Physiotherapy Equipment like treadmills, stationary bikes, resistance bands, weights, balance boards, foam rollers, and range of motion devices; Electrotherapy devices, traction devices, ultrasound machines; and Occupational Therapy Equipment such as hand exercisers and is the Growth Potential Responsible for the Growth of the Rehabilitation Equipment Market? Rehabilitation equipment drivers in physical therapy and disability refer to tools, devices, and technologies designed to help individuals restore or preserve their physical abilities and independence. This category includes a variety of items such as wheelchairs, prosthetics, orthotics, assistive devices, and therapy tools. These tools are essential for rehabilitation programs focused on enhancing mobility, strength, balance, and overall function. What Are the Growing Trends Associated with the Rehabilitation Equipment Market? An Aging Population and Chronic Diseases The growth is driven by the increasing number of patients with an ageing population, with increasing demand for rehabilitation services for management of treatment and healthcare. Technological Advancements The growing advancement in technology, like integration of AI, smart devices, virtual and augmented reality, remote monitoring, and robotics, are some of the major growth factors. Increased Demand for Home Healthcare Increasing focus on patient empowerment and personalised care, and demand for portable and easy-to-use equipment further fuels the growth of the market. Supportive Government Policies and Reimbursement Favorable government policies and support for the development and adoption of he technologies further boost the growth of the market. You can place an order or ask any questions, please feel free to contact us at sales@ What Is the Growing Challenge in the Rehabilitation Equipment Market? The global rehabilitation equipment market is growing rapidly, driven by an aging population, increasing rates of chronic diseases, and technological progress. Nevertheless, issues remain in providing access, affordability, and effective use of this equipment. Rebuilding strength, flexibility, and coordination following injury or illness often demands specialized equipment and can be physically challenging. Additionally, rehabilitation can be emotionally difficult, as patients may experience anxiety, depression, and frustration, all of which can affect their participation in therapy. Regional Analysis: How Did North America Dominate the Rehabilitation Equipment Market in 2024? North America dominated the global rehabilitation equipment market share by 43% in 2024. The growth of the market in the region is driven by the growing aging population, which leads to higher prevalence of chronic diseases, advanced healthcare infrastructure, which requires rehabilitation services and equipment, which fuels the growth of the market in the region. The other key factors that fuel the growth are the technological advancements like integration of AI, IoT, and robotics for automation and for enhancing the treatment and patient outcomes, which promote the growth of the market in the region. Key players like Invacre, Medline Industries, Dynatronics, ReWalk Robotics, and DJO Global also play a crucial role in the growth and expansion of the market in the region. According to Volza's Global Export data, the world shipped out 5,948 Rehabilitation Aid shipments from October 2023 to September 2024 (TTM). These exports were handled by 56 world exporters to 104 buyers, showing a growth rate of 28% over the previous 12 months. Globally, India, China, and the United Arab Emirates are the top three exporters of Rehabilitation. India is the global leader in Rehabilitation exports with 12,028 shipments, followed closely by China with 242 shipments, and the United Arab Emirates in third place with 99 shipments. Get the latest insights on life science industry segmentation with our Annual Membership: What Made Asia Pacific Significantly Grow in the Rehabilitation Equipment Market In 2024? Asia-Pacific is anticipated to grow at the fastest rate in the market during the forecast period. The growth of the market is driven by the growing and increasing prevalence of disabilities and rising awareness of rehabilitation benefits, which increases the demand for the market, along with the expanding healthcare infrastructure in the region, which supports the growth of the market. Other key factors that support growth are the growing geriatric population, expanding healthcare infrastructure, increasing government initiatives for promoting healthcare facilities, and affordability, which promotes the growth of the market in the region. The key players in the region also support the expansion and growth of the market through advancements and the integration of modern technologies. According to Volza's India Export data, India shipped out 6,764 Rehabilitation shipments from October 2023 to September 2024 (TTM). These exports were handled by 20 Indian exporters to 108 buyers, showing a growth rate of 28% over the previous 12 months. Globally, India, China, and the United Kingdom are the top three exporters of Rehabilitation. India is the global leader in Rehabilitation exports with 16,456 shipments, followed closely by China with 5,850 shipments, and the United Kingdom in third place with 2,347 shipments. Segmental Insights By Type How Did the Therapy Equipment Segment Dominate The Rehabilitation Equipment Market In 2024? The therapy equipment segment held a dominant presence in the market in 2024. The market is experiencing growth, fueled by innovations like robotic-assisted devices, virtual reality-based therapy, and smart wearable systems. These tools enhance patient engagement, personalization, and treatment effectiveness, especially for neurological, post-surgical, and chronic pain recovery. Their ability to deliver precise, monitored exercise regimes and promote faster functional restoration is driving demand across hospitals, physiotherapy centers, and home-care settings. This surge supports therapy equipment's supports the growth and expansion of the market. The daily living aids segment is expected to grow at the fastest rate in the market during the forecast period. The market is experiencing strong attention due to addressing the needs of individuals with impaired mobility or chronic conditions. These tools, such as adaptive utensils, grab bars, walkers, and dressing aids, enhance independence, safety, and daily functioning. Their ergonomic designs and ease of use reduce caregiver burden and support aging-in-place. Widely used in home care, assisted living, and outpatient rehab, the growing demand for these aids reflects an increasing focus on quality of life and long-term wellness. Elevate your healthcare strategy with Towards Healthcare. Enhance efficiency and drive better outcomes schedule a call today: By Application Which Application Segment Dominates The Rehabilitation Equipment Market In 2024? The occupational rehabilitation & training segment led the global market in 2024. The growth of the market is expanding rapidly, driven by the need to support individuals recovering from injuries, disabilities, or neurological events in regaining functional abilities for everyday work and personal tasks. This category includes simulation-based training tools, task-specific therapy stations, ergonomic workstations, and adaptive devices designed to rebuild fine motor skills, coordination, and cognitive-motor function. Demand is particularly high among physical and occupational therapy clinics, vocational centers, and home-based rehab settings, fostering innovation and market growth. The physical rehabilitation & training segment is anticipated to grow with the highest CAGR in the market during the studied years. The growth of the market is driven by the increasing demand for recovery support after surgeries, neurological events, and musculoskeletal injuries. This category covers tools such as resistance bands, therapeutic exercise machines, gait trainers, functional electrical stimulation systems, and balance boards, all designed to rebuild strength, flexibility, mobility, and coordination. Widely adopted in hospitals, physiotherapy centers, sports rehab clinics, and home-based care, these solutions enable faster and more effective patient recovery, fueling robust growth and innovation in the market. By End-Use How Did Hospitals and Clinics Segment Dominate the Rehabilitation Equipment Market in 2024? The hospitals & clinics segment held the largest share of the market in 2024. Healthcare facilities rely on a wide range of devices, from therapeutic exercise machines and gait trainers to robotic-assisted systems and electrical stimulation units, to support patient recovery and physical rehabilitation. Hospitals and clinics require high-quality, durable, and clinically validated equipment to deliver effective treatment across orthopedics, neurology, and post-surgical care. Their heavy utilization and preference for advanced technology drive substantial demand, fueling innovation and expansion in the rehabilitation equipment space. The rehabilitation centers segment is predicted to witness significant growth in the market over the forecast period. These dedicated facilities specialize in comprehensive recovery programs and invest heavily in a diverse range of therapeutic technologies from robotic-assisted devices and gait trainers to virtual-reality systems and functional electrical stimulation units. Their focus on long-term, multidisciplinary care for patients recovering from strokes, spinal cord injuries, and mobility impairments drives demand for advanced, customizable, and patient-centric equipment. This strong utilization supports steady market growth and ongoing product innovation. Recent Developments In July 2025, Jin Medical International announced the launch of a production plan in Chuzhou, which will help in accelerating the global delivery of rehabilitation medical equipment, with expert rehabilitation technology and an expanding ecosystem. Browse More Insights of Towards Healthcare: The veterinary rehabilitation services market is worth USD 1 billion in 2024 and is projected to reach USD 3.01 billion by 2034, growing at a rate of 11.74% per year. The stroke rehabilitation market stands at USD 285 million in 2024 and is likely to reach USD 817.06 million by 2034, expanding annually at 11.24%. The medical rehabilitation services market is valued at USD 270.58 billion in 2024 and is expected to grow to USD 492.4 billion by 2034, at a yearly growth rate of 6.17%. The behavioral rehabilitation market is projected to grow from USD 171.88 billion in 2025 to USD 235.89 billion by 2034, with a growth rate of 3.58% per year. The rehabilitation robots market is estimated at USD 430 million in 2024 and is projected to rise to USD 1.77 billion by 2034, growing rapidly at 15.24% annually. The automated blood processing equipment market is worth USD 2.12 billion in 2024 and is expected to grow to USD 4.41 billion by 2034, with an annual growth rate of 7.65%. The medical equipment maintenance market is valued at USD 46.16 billion in 2024 and is projected to reach USD 121.94 billion by 2034, expanding at a rate of 10.04% per year. The dental equipment market is estimated at USD 11.95 billion in 2024 and will likely grow to USD 22.1 billion by 2034, with a growth rate of 6.34% annually. The personal protective equipment (PPE) market was valued at USD 79.57 billion in 2023 and is projected to reach USD 171.66 billion by 2034, growing at 7.24% per year. The surgical equipment market was estimated at USD 16.91 billion in 2023 and is expected to grow to USD 45.61 billion by 2034, with an annual growth rate of 9.44%. Top Players in Rehabilitation Equipment Market: Activatek, Inc. Baxter International Dynatronics Ekso Bionics Ergoline GmbH Hocoma AG Invacare Corporation Life Care Systems Medline Industries MR Medica Prism UK Medical Ltd. RehabGroup, Inc. Stryker Corporation Segments Covered in The Report By Type Therapy Equipment Daily Living Aids Medical Beds & Related Products Reading, Writing, and Computing Aids Bathroom & Toilet Assist Devices Others Mobility Equipment Wheelchairs & Scooters Powered Wheelchairs Mobility Scooters Manual Wheelchairs Walking Assist Devices Canes Crutches Walkers Body Support Devices Patient Lifts Stings Others Exercise Equipment Lower-Body Exercise Equipment Upper-Body Exercise Equipment Full-Body Exercise Equipment By Application Occupational Rehabilitation & Training Physical Rehabilitation & Training By End-Use Hospitals & Clinics Rehabilitation Centers Home-Care Settings Physiotherapy Centers Others By Region North America U.S. Canada Asia Pacific China Japan India South Korea Thailand Europe Germany UK France Italy Spain Sweden Denmark Norway Latin America Brazil Mexico Argentina Middle East and Africa (MEA) South Africa UAE Saudi Arabia Kuwait Get the complete strategic report with expert insights, trends, and competitive benchmarking: You can place an order or ask any questions, please feel free to contact us at sales@ Gain access to the latest insights and statistics in the healthcare industry by subscribing to our Annual Membership. Stay updated on healthcare industry segmentation with detailed reports, market trends, and expert analysis tailored to your needs. Stay ahead of the curve with valuable resources and strategic recommendations. Join today to unlock a wealth of knowledge and opportunities in the dynamic world of healthcare: Get a Subscription About Us Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth. Our Trusted Data Partners Precedence Research | Statifacts | Towards Packaging | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Consumer Goods | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire For Latest Update Follow Us: in to access your portfolio
Business Wire
an hour ago
- Business Wire
AM Best Downgrades Credit Ratings of Construction Guarantee Cooperative
HONG KONG--(BUSINESS WIRE)--AM Best has downgraded the Financial Strength Rating to A (Excellent) from A+ (Superior) and the Long-Term Issuer Credit Rating to a+ (Excellent) from 'aa-' (Superior) of Construction Guarantee Cooperative (CG) (South Korea). The outlooks of these Credit Ratings (ratings) have been revised to stable from negative. The ratings reflect CG's balance sheet strength, which AM Best assesses as strongest, as well as its adequate operating performance, favourable business profile and appropriate enterprise risk management (ERM). The rating downgrades reflect the revision of AM Best's assessment of CG's operating performance to adequate from strong, following a deterioration in its underwriting profitability in recent years, which AM Best expects will remain pressured over the short to medium term. The company recorded two consecutive years of underwriting losses in 2023 and 2024, in addition to the first half of 2025. This was due to a material rise in guarantee claims payment and a sizeable provision of guarantee claims reserves from liquidity pressure on an increased number of its members amid a downturn in the domestic construction industry. In addition, CG's increased exposure to market risk since 2022 under its realigned investment strategy has been adding additional volatility to its profitability. Despite some mitigative measures by the company, its performance is likely to remain moderate given the ongoing uncertainties on the industry recovery and the general time lag between the construction industry cycle and performance of the guarantee business. CG's risk-adjusted capitalisation is expected to remain comfortably at the strongest level, as measured by Best's Capital Adequacy Ratio (BCAR), underpinned by a large capital base of KRW 6.8 trillion (USD 4.6 billion) as of year-end 2024, extremely low underwriting leverage, favourable liquidity and a debt-free position. AM Best also expects that the company may receive financial support from the government in case of a significantly stressed scenario. Established under the Korea Construction Financial Cooperative Law, CG is a government-designated surety underwriter for general contractors and plays a key supporting role in implementing government policies related to the construction industry in South Korea. CG has the largest share of the construction surety segment and a strong membership base, which represents the majority of the general contractors in the country. The majority of project owners of CG's surety bonds are central and local governments, which adds stability to its overall business volume. Meanwhile, the company has been diversifying its business gradually to overseas surety business and construction-related insurance products over the past few years to alleviate its concentration risk within the domestic construction surety segment. Negative rating actions could occur if there is a significant deterioration in CG's balance sheet strength fundamentals. Positive rating actions could occur if the cooperative's operating performance demonstrates consistently strong and resilient results under various conditions of the overall economy and construction industry with mitigated investment volatility to support the bottom-line. Ratings are communicated to rated entities prior to publication. Unless stated otherwise, the ratings were not amended subsequent to that communication. This press release relates to Credit Ratings that have been published on AM Best's website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best's Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings. For information on the proper use of Best's Credit Ratings, Best's Performance Assessments, Best's Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best's Ratings & Assessments. AM Best is a global credit rating agency, news publisher and data analytics provider specialising in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit Copyright © 2025 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.
Yahoo
2 hours ago
- Yahoo
XRP Drops 19% From Highs as $113M in Longs Liquidated
XRP (XRP-USD) plunged 19% from eight-year highs this week as a wave of liquidations rattled crypto markets, though analysts say the selloff is a healthy correction not a red flag. Warning! GuruFocus has detected 3 Warning Signs with NIO. The token dropped to $2.95 on Thursday after reaching a multi-year peak of $3.66, losing 12.5% in 24 hours. XRP long positions worth $113.6 million were liquidated, according to CoinGlass, including $106.8 million in longs. The broader crypto market also dipped 3% to $3.79 trillion, with total liquidations nearing $1 billion. The pullback followed weeks of overbought momentum. On the weekly chart, XRP's relative strength index dropped from 71 to 61, while the daily RSI fell to 56 after peaking at 88. Analysts say the correction could open the door to a more sustainable rally if the $3 support level also the 100-period simple moving average holds. This is a healthy shakeout, said market analyst XRPunkie. The $10$15 target remains on the table. Other analysts said the retreat is part of a broader cooldown after leverage overheated across altcoin markets. Market watchers are now eyeing $2.60 as the next key support if bulls fail to hold the line. This article first appeared on GuruFocus.
